The Department of Health and Human Services has sent a two-page letter to “Health Care Providers, Health Care Risk Managers, and State Medical Boards,” requesting they change their protocols and procedures when treating minors with gender dysphoria.
HHS sent a letter to health care providers, risk managers, and state medical boards urging immediate updates to treatment protocols for minors with gender dysphoria based on HHS’ comprehensive review that found puberty blockers, cross-sex hormones, and surgeries have very weak evidence of benefit, but carry risk of significant harms, including sterilization. Providers should no longer rely on discredited guidelines that promote these dangerous interventions for children and…
